Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

DOI10.1016/S1470-2045(09)70154-8WikidataQ34606771 ScholiaQ34606771MaRDI QIDQ89955

Geneviève Laureys, Victoria Castel, Sophie Bravo, Paola Scaruffi, André Oberthuer, Janice Kohler, Ulrike Pötschger, Katleen De Preter, Jo Vandesompele, Valérie Combaret, Jean Bénard, Rosa Noguera, Marta Piqueras, Adela Cañete, Michael D Hogarty, Olivier Delattre, Gian Paolo Tonini, Gudrun Schleiermacher, Frank Speleman, Patrick Mcgrady, Isabelle Janoueix-Lerosey, Nadine Van Roy, Katrien Swerts, Jean Michon, Bárbara Marques, Matthias Fischer, Ruth Ladenstein, Peter F Ambros, Hervé Rubie, Klaus Beiske, Arlene Naranjo, Jan Hellemans, Wendy B London, Bruno De Bernardi, Liesbeth Vercruysse, Joëlle Vermeulen

Publication date: July 2009

Published in: The Lancet Oncology (Search for Journal in Brave)

Related Items (1)

vermeulen

This page was built for publication: Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study